VISIONARY DEAL: Bausch + Lomb, a top maker of contact lenses, is being bought for $8.7 billion by Canadian drugmaker Valeant Pharmaceuticals to expand Valeant’s smaller ophthalmology business.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.